Glofitamab User Reviews & Ratings
Brand names: Columvi
Glofitamab has an average rating of 8.0 out of 10 from a total of 1 reviews on Drugs.com. 100% of reviewers reported a positive experience, while 0% reported a negative experience.
| Condition | Avg. Rating | Reviews | Compare |
|---|---|---|---|
| Diffuse Large B-Cell Lymphoma | 1 reviews for Diffuse Large B-Cell Lymphoma | 20 medications |
Are you taking this medicine?
Your review helps others make informed decisions.Reviews may be edited to correct grammar/spelling or remove inappropriate content. Reviews appearing to come from parties with a vested interest are not published. This information is not intended to endorse any medication and should not replace the expertise and judgment of healthcare professionals.
More about glofitamab
- Check interactions
- Compare alternatives
- Reviews (1)
- Side effects
- Dosage information
- During pregnancy
- Drug class: bispecific T-cell engagers (BiTE)
- Breastfeeding
- En español
For Diffuse Large B-Cell Lymphoma "Tumor located in the chest cavity. Was misdiagnosed as pleurisy and treated with repeated doses of prednisone. Experienced severe pain, and after weeks of pain, eventually was admitted and received a diagnosis of diffuse large B-cell lymphoma. This was the 4th occurrence for me. Treatment began according to prescribed methodologies, and chest pain diminished shortly thereafter. Side effects seem to be limited to bone and muscle pain, which limit mobility."